Pre-operative tranexemic acid versus eethamsylate in reducing blood loss during cesarean section

Pre-operative tranexemic acid versus ethamsylate in reducing blood loss during cesarean section

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201802002761404

Enrollment

120

Registered

2017-11-13

Start date

2017-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Decreasing blood loss

Interventions

Tranexemic acid group

Ethamsylate group

Placebo group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All women undergoing elective cesarean section except those with placenta Previa

Exclusion criteria

Exclusion criteria: Emergency cesarean section Placenta previa Any contraindications or hypersensitivity to any of the treatments

Design outcomes

Primary

Measure	Time frame
Amount of blood loss	—

Secondary

Measure	Time frame
Need for blood transfusion ;Percentage of postpartum hemorrhage ;Need for further interventions to combat postpartum hemorrhage	—

Countries

Egypt

Contacts

Public ContactHaitham Torky

October 6th University

haithamtorky@yahoo.com+201001230161

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026